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Part 1: Abstract  
Project title: Social Prescribing: integrating GP and Community Assets for Health 
 
Lead organisation: City and Hackney Clinical Commissioning Group 
 
Partner organisation: Dr Marcello Bertotti, Caroline Frostick, Gail Findlay, Prof Angela 
Harden, and Prof Gopal Netuveli, Prof Adrian Renton (Institute for Health and Human 
Development), University of East London; Dr Dawn Carnes, Ratna Sohanpal and Dr Sally 
Hull (Queen Mary University of London) 
 
Lead Clinician: Dr Patrick Hutt (MBBS, MRCGP), Queensbridge Group Practice, Clinical 
Lead City and Hackney Clinical Commissioning Group.  
 
Current health policies are concerned with merging health and social care, effectively 
managing long-term conditions in the community, reducing social isolation, and at the same 
time minimising expenditure1. Social prescribing (SP) is a potential solution to these 
objectives.   
 
‘We are seeing a big growth in social prescriptions where GPs are saying that actually the 
root cause of this person’s problems is isolation and loneliness, so effectively what I’m going 
to prescribe is that you join a lunch club or something like that to make sure you have 
company in your life [..] The NHS is taking a more holistic view of what it takes to address 
people's medical problems than it did before and I do not think that is something we would 
want to stand in the way of’ Jeremy Hunt, Health Secretary2.  
 
The term SP encompasses different types of links between primary care and community 
organisations ranging from an unstructured information service (i.e. leaflet) to a 
sophisticated holistic approach involving a facilitator3. Building on the latter of these, SP in 
City and Hackney CCG is one of the most ambitious and innovative in the UK to date:  
(i) Involved a large number of GP practices (23). 
(ii) Set broad inclusion criteria for referral, reflecting the diversity of the people who 
present to their GPs4;  
(iii) Signposted patients to a wide range of services (85 organisations);  
(iv) Had dedicated and trained SP coordinators which supported 737 participants 
(Feb 2014 - July 2015) for up to eight one hour sessions to co-produce a well-
being plan;  
(v) Rigorous evaluation included a control group and economic evaluation – aiming 
to fill gaps in the existing evidence base5 6.    
 
                                               
1 Department of Health (2010) 
2 GP online, 10th Dec 2014 
3 See Kimberlee (2015) and Brandling and House (2007) for a more detailed discussion 
Please see appendix 5 for details of the inclusion criteria for referral and detailed project aims 
5 Grant et al 2000; Dayson et al 2013 
6 Kimberlee, 2015; CRD, 2015 
Shine 2014 final report 4/33 
The general health and wellbeing of participants surveyed has remained stable over the 
intervention period. Quantitative analysis showed no statistically significant change in health 
outcomes between intervention and control groups. However, qualitative interviews (12 out 
of 15) revealed ‘life changing’ experiences.  The role of the SP coordinator (SPC) was key to 
this success. The average cost per patient of providing SP is between £225 and £270. 
Savings may have been realised through a decline in A&E attendance but may have been 
offset by an increase in General Practice consultation rates during the intervention period.  
 
There is room to increase referrals to SP by GPs. The referral step from SPC to community 
organisation needs to be developed further, e.g. referral form, to help local organisations feel 
part of the SP project. Further work is required to establish which patients benefit most from 
SP and the characteristics community organisations that improve health and wellbeing the 
most. National collaboration is required to share learning, develop outcome measures, and 
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Part 2: Quality impact: outcomes  
 
23 GP practices in City and Hackney7 referred 737 patients to three social prescribing 
coordinators (SPCs) employed by Family Action (FA)8. SPCs assessed individuals’ needs 
and aspirations before connecting patients to appropriate, mainly non-clinical, community 
services9 delivered by 85 statutory and voluntary groups (see Fig 1). The DNA (Did Not 
Attend) rate at first appointment with the SPC was 11% (Chart 1)10. Qualitative evidence 
shows a positive impact due to SP but the quantitative data does not show any statistically 
significant change due to the intervention. An economic and process evaluation was 
conducted (see Part 3 and 4).  
 















Chart 1: Breakdown of consultations provided by SP coordinators to clients 
                                               
7 These 23 practices were from three consortium in City and Hackney – which were selected by the CCG after 
invitations to participate were circulated prior to the launch of the pilot.  
8 FA is a Hackney based third sector organisation which run Social Prescribing between Feb 2014 and July 2015 
9 Lunch clubs, psychological counselling, volunteering, physical activity (e.g. yoga, walking) and specialist 
support with health, employment and legal issues. 
10 This is better than other social prescribing interventions such as ‘Equally Well’ which had 36% DNAs at first 
appointment. Although complete data about attendance of participants to community organisations was not 
available for the overall period, in the last quarter of the intervention FA reported that about 70% of participants 
attended community activities.  





Qualitative interviews with patients: experience with services 
 
Participants (N=15) suffered from a wide range of co-morbidities. The sample was well 
balanced re gender (female/male), ethnicity (White/non-White), and 66% of respondents 
were aged 50 or over. About 33% of respondents attended one or two sessions. The 
selection of respondents was only partially randomised11. 
  
Participants’ experience was, overall, positive or extremely positive. Re-connecting with the 
world and renewed hope for the future were the two main patient experience themes that 
emerged. Patients reported suffering from a range of physical and psychological challenges; 
the most common being social isolation, confirming that a key target group for SP was 
reached.12 Benefits of SP included becoming involved with organisations on their doorsteps 
and interacting positively with local people. Several patients spoke of the structure that this 









Patients’ interaction with SPCs was key to their progression and experience of SP13. 
Patients spoke positively of being given the time and space to discuss their needs, feeling 
heard, and the proactive focus of the intervention, e.g. learning new skills. Several patients 
described ‘life-changing’ results often relating to employment and social networks14. 
 
                                               
11 Many participants did no reply to initial contact, thus we had to rely on FA selecting participants that may have 
been more willing to participate.   
12 This was a key target group for the CCG 
13 The same finding was highlighted in a range of other studies (Brandling et al 2010; White, Kinsella and South, 
2010), 






Breakdown of Consultations (n=624) (Feb 14-Jul 15)  
One consultation
Between 2 and 4
consultations




“It’s done me a world of good, taken me out of the house, given me a 
routine and given me a sense of purpose and…hope. It’s given me back 
my confidence” (Patient) 
 


















Participants had no knowledge of the term ‘social prescribing’, the provider organisation 
(FA), or the term ‘well-being/social prescribing coordinator’ but could remember the personal 
names of SPCs referring them and the types of activities they had been referred to. Most 
agreed more information, e.g. a leaflet from the GP, would be helpful. Experiences of the 
referral process were generally good, with no reports of long wait times to see the SPC. 
Appointment numbers with SPC varied but patients were generally satisfied that they 
received sufficient input to meet their needs.  
 
 
Patient reported outcomes: health, well-being, anxiety, depression, active 
engagement, and quality of life  
 
A control group (six GP practices in City and Hackney) were matched to intervention group 
(SP respondents).15 Data was collected at baseline and eight months from both groups.16  
 
Table 1: Demographic details for intervention and control areas  
 
 Intervention  (N=184)(*) Control (N=302)(**) Correlations with treatment group 
Age Median 56 (range 18-95) Median 58 (range 24-83) P=0.560 

















                                               
15 Inclusion criteria in the control group: age group older than 23 and younger than 85 years old suffering from at 
least one of the following:  depression, anxiety, type 2 diabetes. Exclusion criteria: palliative care and 
housebound  
16 The intervention effectively targeted socially isolated and ethnic diversity of the area is well represented. The 
control group were well matched (health profile, age, gender), though were more likely to live with others, have 
higher educational qualifications and be employed.  
 
“Done qualifications at Tesco. The Job Centre really happy with me. 
Before I was on capacity benefit and I thought I’ll change my life and I 
have I’m really happy. I do want to work and Job Centre knows that.” 
(Patient) 
“It (social prescribing) gave me the motivation to think I might be ready to 
go back to work. It helped me deal with my depression, prepared me to go 
back to work and made me feel useful.” (Patient) 
 





























To 16 years 














Table 2: Change in health profile from baseline to follow up  
 Scale Baseline 
 
8 months Follow up 






















6 good as it can be 
0 bad as it can be 
(mean) 
2.8 3.6 2.8 3.9 
Anxiety (*) 21 extremely anxious 
0 not anxious at all 
(mean) 
11.3 8.1 11.2 7.6 
Depression (*) 21 extremely anxious 
0 not anxious at all 
(mean) 





5 poorly integrated to 
20 highly integrated 
(mean) 
13.5 13.7 13.5 14.1 
A&E visits in past 3 months (mean) 0.4 0.3  0.3 0.5 
 (*) Scores between 0-7 in both anxiety and depression scales are considered normal, with 8-10 borderline and 
11 or over indicating clinical ‘caseness’. 
 
Respondents from the intervention group, in keeping with the CCG target population, 
showed poor general health and clinical anxiety/depression, although ‘wellbeing in the past 
week’ was neither good nor bad (Table 2). Logistic regression analysis showed no 
statistically significant change in health, well-being, anxiety, depression, or A+E visits due to 
the SP intervention, even after controlling for age, gender, ethnicity, living arrangement and 
work status (see appendix 4).  
 
 There may be different reasons for such result including: 
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(i) Follow up sample size for the intervention (n=65) is small for regression analysis 
as it represents only 10% of the population that attended social prescribing.   
(ii) Limited information about the type and number of activities people attended. Lack 
of impact may be due to lack of attendance rather than lack of effectiveness of 
the intervention.17 
(iii) There is considerable uncertainty about the ‘right’ follow up period when 
considering complex interventions such as SP and issues about the appropriate 
survey instruments to be used.  
The evaluation also examined health related quality of life18 at baseline and eight months 
follow up and showed a statistically positive change in both intervention and control groups 
(Table 3). However, as the control group has also shown a positive change, the positive 
change in the intervention may not be due to the effect of the intervention but to other 
reasons.19 
 
When breaking down the different quality of life components (see appendix 8) ‘mobility’ 
improves in the intervention, while worsens in the control. The intervention also recorded a 
greater improvement in ‘usual activities’, and ‘pain/discomfort’ in comparison to the control.  
An improved ability to engage in physical activities is surprising as most of the literature on 
social prescribing points to its importance for improving mental rather than physical health. 
 
 




EQ-5D score 8 
month follow up 
Paired t-test p-value 
(significance 
between baseline 
and follow-up) N Mean SD N Mean SD 
Control group 120 0.606 0.370 120 0.643 0.359 0.067 
Intervention group 66 0.342 0.389 66 0.402 0.382 0.058 
Unpaired t-test p-
value (significance 
between Control and 
Intervention) 








                                               
17 Although in the last quarter of the intervention SPCs reported that about 75% of participants did go on to 
participate in community activities. 
18 Each of the 5 dimensions (mobility, self-care, usual activities, pain/discomfort and anxiety/depression) to 
EuroQol are scored on three levels 
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Part 3: Cost impact 
The economic evaluation assessed costs and potential savings due to SP20.  The direct cost 
of the project was calculated by looking at the number of sessions and time spent by SP 
coordinators with each client. As SP coordinators included people with a background in 
nursing and social work, a full economic cost for these professions was used to calculate the 
average cost per patient21 as being between £225 and £270 (Table 4).  The average cost 
per patient was multiplied by the number of patients supported to assess the value of social 
prescribing to City and Hackney CCG. As the CCG has invested £150K and the total cost 
calculated is £168K (£269.58*624), the investment from the CCG appears cost-effective 
even though the number of referrals (chart 3) is below what was initially expected.  
 
Table 4: Costs of delivering the intervention £ 2014* 
 
Average cost per 
patient 
SD Median IQR Min Max 
Nurse 224.62 180.00 187.00 200.00 0.00 1064.00 
Social 
Worker 
269.58 215.51 217.25 237.00 0.00 1382.50 
 * Unit costs 2014 from [1], Curtis L, Unit costs of health and social care 2014. 
Community mental health nurse, Curtis 10.2: £74/hour face-to-face contact; £52/hour patient-related, 
used for non-face-to-face contact time. 
Social worker, adult services, Curtis 11.2: £79/hour client-related, used for face-to-face contact and 
non-face-to-face time. 
 
The average cost per patient does not include indirect costs associated with service delivery 
from community organisations (although these were not funded by the CCG). On average, 
SP coordinators referred clients to just over one activity (1.17), although this could range 
from zero to seven activities in isolated cases. Limited data was available, and no data 
specified the type of activity clients attended. Thus, it was not possible to examine resources 
involved.  As there was no significant gain in quality of life health in the intervention as 
compared to control, cost per Quality Adjusted Life Years was not calculated.22   
Mean A&E visits in the last three months at baseline and follow up were analysed in both 
intervention and control groups (Table 2). There is a decline in mean A&E attendance by 
25% in the intervention group compared to an increase in mean A&E visits in the control 
group by 66%.  Savings from decline in A&E attendance in the intervention group are about 
£1,600 as they only refer to the population of respondents.  
 
General Practice consultation rates in both intervention and control areas over a two year 
period (July 2013-June 2015) were also analysed.23 (chart 2). Consultations per patient over 
                                               
20 We kindly acknowledge the advice of Heather Gage, Peter Williams and Clareece Kirby from Surrey University 
21 Social worker, adult services: 11.2: £79/hour client-related, used for face-to-face contact and non-face-to-face 
time (Curtis, 2014) 
22 An economic evaluation of a referral facilitator (Grant et al 2000) found that the intervention was clinically 
beneficial but at higher cost 
23Data for the controls covered 3,235 patients (62,945 consultations). Data from intervention practices (13,344 
consultations) covered 498 people who had been referred to SP. Examination of the consultations revealed these 
included contact with practice management and support staff, including receptionists and secretaries. Since costs 
of health professionals are “fully loaded” i.e. include allowance for practice overheads and support staff, all 
consultations recorded for staff who do not provide direct patient care were removed. 
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the two-year period were higher in the intervention than control group (table 5), consistent 
with their lower health status24.  
 
Table 5: Consultation rates (Number of consultations per year per patient) 
 
Consultation rate in 
Year 1 (July 2013 – 
June 2014 
Consultation rate in 
Year 2 




year 1 vs. year 
2) N Mean SD N Mean SD 
Control group 3225 8.36 7.4 3225 8.3 6.68 0.598 
Intervention 
group 498 11.49 8.32 498 12.78 8.17 0.000123 
 
 
Chart 2: Mean consultation rates for intervention and control groups 
 
 
Pre and post referral consultation rates were calculated on the 420 patients who had a 
referral date in the data base (Table 6). There was a significant difference between the 





Table 6: Consultation rates (per year) per patient of the intervention group 
                                               
24 Carlisle et al (2002); Worrall et al (1997) 
25 As the intervention came into effect in April 2014 and new referrals to FA continued throughout year 2, use of 
calendar years provided an imprecise measure of the effect of the intervention.   In order to explore the impact of 
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Consultation rate 
before referral date 
Consultation rate 
after referral date 
Paired t-test p-value 
(significance between 
rates before and after 
referral date) N Mean SD N Mean SD 
Intervention 
group 420 12.32 8.03 420 13.21 9.40 0.025 
 
Detailed analysis of General Practice consultation rates is needed to ensure that 
appointments with SPCs did not contribute to the total number. Moreover, the economic 
evaluation does not currently take into account other potential benefits generated by the 
intervention such as clients volunteering, retuning to work (contributing as taxpayers and 
with reduced welfare state support).   
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Part 4: Learning from your project  
 
The process evaluation has informed this section26. We also produced a benchmark model 
(see appendix 6) based on the stakeholder meetings and informed by wider literature that 
could be used more broadly to inform social prescribing in City and Hackney CCG and 
beyond.  The key objectives to implement, refine, and evaluate SP in pilot sites across City 
and Hackney has been achieved.  
 
Enablers: funding, social prescribing coordinators, stakeholders’ buy-in 
 
The concept of SP appeared to resonate with health professionals locally as a potential 
solution to the challenges faced by their patients and the difficulty of clinicians staying up to 
date with the range of activities available locally. The Building Health Partnership 
programme funded a series of community workshops to help design the social prescribing 
model prior to its launch.27 City and Hackney CCG funding was supplemented by Shine for 
further evaluation.  
 
The contribution of SPCs was crucial to the success of the intervention. The SPCs skill set 
and their hour-long appointments meant they were able to accurately assess client’s needs 
as well as referring them onwards. SPCs were also tasked with mapping services locally and 
engaging volunteers. Co-location of SPCs in practices helped to establish rapport with the 
clinical team and facilitate GPs directly booking patient appointments. As the project 
progressed community organisations were able to approach SPCs directly rather than trying 













The relationship between FA and most community organisations was a positive feature of 
the intervention. Evidence from interviews with community organisations showed that clients 
had been referred appropriately by SPCs and had accurate expectations of the service 
available. Most referrals were managed by about 10 organisations, but a total of 85 
organisations participated to social prescribing showing an attention towards the variety of 
support provision as well as clients’ needs and choices, particularly in terms of geographic 
proximity. The structure of the project – which included quarterly steering group meetings 
and learning events – meant that a range of partners could share emerging learning. 
                                               
26 Interviews were conducted with social prescribing coordinators (6), GPs (2), staff from City and Hackney CCG 
(4) and community organisations (3). Two learning events were also held (July 2014 and March 2015) with key 
stakeholders including commissioners, voluntary sector service providers, practice nurses, GPs, volunteers and 
patients to discuss the progress of social prescribing, identify strengths, weaknesses and priorities for the future. 




“I tell patients that we have a lady whose job is to link them in with what is going 
on in the community, and that she is an expert in finding community groups of all 
kinds [..] Social Prescribing worker [i.e. coordinator] we have is very helpful and 
patients like her” (General Practitioner). 




Challenges and Solutions: referral numbers, branding, involvement of third sector  
 
The capturing learning events highlighted the different perspectives people had about SP 
(see elephant analogy below). For example, GPs were not so aware of what happened once 
patients were signposted on to community organisations. Likewise some community 
organisations were not aware that people were visiting them as a result of SP – particularly 
as for most activities there was no standardised referral form they were often drop in. There 
were also culture differences that were subtle but important for appreciating the complexity 
of the pathway: GPs referred to ‘patients’, SPCs to ‘clients’, and some voluntary 
organisations to ‘people.’ Awareness of these different perspectives is important when trying 
to establish referral pathways amongst professional groups that have not worked with each 




Gross S (1980) ‘An elephant is soft and mushy: cartoons by S. Gross’, Dodd, Mead 
 
It was a challenge to involve the community and voluntary sector after the initial consultation 
in the SP pathway given there was little direct funding to support them. Participants to 
learning events reported that in most cases this led to limited sense of belonging to the SP 
pathway and limited monitoring of community activities. Although challenging to administer, 
alternatives may include a ‘payment by result’ strategy as developed by Newham 
Community Prescribing Scheme (Bertotti et al, 2014), which could make community 
organisations more accountable, sustainable and facilitate monitoring of the intervention.  
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Two of the SPCs left after the first year, which affected continuity. There were also three 
successive management teams involved from the CCG – though good working relationships 
have been consolidated quickly thanks to the steering group.  
 
GP referral rates have been inconsistent (see chart 3) and concentrated in a number of GP 
practices28. SP referral numbers could be increased.29 Lack of time within busy 
consultations, forgetting about the availability of the service, and scepticism about patients 
effectively attending community activities once referred were reasons GPs cited as barriers 
to referral. SP was also set up during a time of unprecedented national and local 
reorganisation. Strategies to improve referrals involved; feedback letters sent to clinicians by 
the SP Coordinators, GP education events, encouraging SPC attendance of clinical 
meetings, information stalls within practice reception areas, and insertion of a ‘pop up alert’30 
(‘Consider referral to Social Prescribing Service?’) into the electronic records at one practice 












Chronic disease templates within electronic records could include prompts for GPs to refer 
to SP coordinators. Maximising the potential of centralised databases such as 
www.hackneyicare.org are important to ensure that a robust and up to date directory of 
community activities, accessible to health professionals and patients, reflects the knowledge 
that SPCs develop in their role. Widening referrers to SP, e.g. pharmacists, physiotherapists, 
psychologists, might help increase numbers. Self-referral is also an option to consider. 
Though these options potentially risks diluting potential of social prescribing as a tool within 
the GP consultation. Outcomes need to be fed back to clinicians so they learn what happens 
to their patients.  
 
There is scope to consolidate the ‘brand’ of social prescribing.31 Patients might be more 
aware of being referred to SP and hence facilitate evaluation. An information leaflet for 
patients at the point of referral would help. Referral forms to community organisations would 
also make community organisations when a patient had been referred onwards via SP. As 
further services emerge locally, there is a greater challenge to ensure that duplication is 
minimised – currently in City and Hackney a number of organisations are setting out to act 
as navigators and to carry out ‘social prescribing.’ 
 
                                               
28 This is confirmed by other studies (Brandling et al, 2011) 
29 As confirmed by some literature (Grant et al 2000; Friedli, Vincent and Woodhouse, 2007), and our own 
evaluation (online surveys with GPs, monitoring data and qualitative interviews) the potential for GP referral has 
not been maximised.  
30 However, this needs to be specific enough in order not to lose its applicability (see Brandling et al, 2011).  
31 For example a number of different terms were used during this project, e.g. ‘social prescribing coordinator’ and 
‘well-being coordinator’ to describe the same role 
“The terrible thing is that I referred five but I should have referred about 15 
times that. Although I am very enthusiastic about it, it is hard to keep in 
front of your mind, and that’s the challenge!” (General Practitioner) 
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The design of key performance indicators (KPIS) for FA by the CCG was a challenge as 
evidence from similar projects elsewhere was limited.32 Such data on KPIS could be shared 
between CCGs to allow realistic targets, e.g. for referral numbers, to be set for start up SP 
projects. Learning needs to be shared nationally as further SP projects emerge. The 
challenge remains to find out which patients benefit most from referral to SP and which 












                                               
32 Although in the first quarter targets were met, referrals averaged about 50% of set target in the following 
quarters, thus the number appear to be low. On reflection, the initial target was too high and did not account for 













actual referrals expected referrals
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Part 5:  Plans for sustainability and spread  
Sustainability beyond the funding period 
We are making a strong case to continue the funding, which is secured until April 2016. In 
the short term the project plans to roll out to other GP sites in City and Hackney, with some 
additional funding. As CCGs and local authorities are both facing substantial cuts, the future 
of social prescribing is likely to rest on a closer collaboration between these coalescing 
around a set of agreed criteria and objectives perhaps using the Health and Well-being 
boards as a negotiating mechanism.  
 
CCG funding would be ideal – but it would also be useful to work with partners who like the 
concept of social prescribing and are keen to see the model evolve (appendix 7). There is 
great potential to develop the City and Hackney service – given its population approach in a 
diverse range of GP practices – so that other parts of the country could readily import it.  
 
As many different small interventions are operating in Hackney in different health areas and 
pathways, we are considering the design of a ‘universal point of access’ which would reduce 
duplications and maximise investment in the local health economy. However, this is likely to 
need substantial initial investment to align different partners and interests, thus we seek 
partners to direct social prescribing towards the implementation of this model.  
 
We are exploring the platform for the www.hackneyicare.org website to see whether 
additional funding might allow a more easily navigable format for health and voluntary sector 
users. It would be useful to capture the knowledge the SPCs are gathering so that it can be 
shared. A readily accessible database with client feedback, and clinician feedback might be 
useful social network 
 
In collaboration with UEL, we are also planning to apply for additional dissemination funding 
from the Health Foundation to make use of online media, build a website to act as an online 
forum and evaluation data repository. This will bring together both practitioners and 
researchers to discuss different models, good practice, challenges for the implementation of 
social prescribing and methods for evaluating its impact. Alongside this, we would like to use 
the funding from the Health Foundation to generate a short movie to capture the experience 
of some social prescribing clients and other stakeholders including GP practices and use 
that for further dissemination.  
 
Conferences and awards 
 
 Abstract article accepted for the Royal College of General Practitioners Conference 
(Glasgow, October 2015) 
 We are planning a journal publication on a comparison between models of social 
prescribing to highlight good practice and review existing literature on impact of 
social prescribing schemes.  
 We are planning a journal publication reporting on the impact of social prescribing in 
City and Hackney 
 
Funding applications 
Hackney and City CCG and University of East London are hoping to apply for funding from 
the National Institute for Health Research to conduct a Randomised Controlled Trial on the 
effectiveness and cost-effectiveness of social prescribing initiatives. Comparable initiatives 
need to be identified.    
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Appendix 2: Resources from the project 
Qualitative interviews with social prescribing clients: main themes 
 
 Re-connecting with the world 
“Before I do nothing I was in bad place. I come out of myself and talk to people.” 
“I do coffee morning as volunteer and meals for elderly. I work with elderly with dementia I’ve 
been challenging myself and people really nice, I have problems and didn’t think there were 
nice people in the world but I was wrong.” 
“I do volunteer work, I’ve been loving it and enjoying it and meeting people.”  
 “The experience has been lovely I been making friends I walk down street now and every 
time I see people they say hello to me now, before they never say hello to me. I didn’t do 
nothing before.”  
 “Best thing has been meeting new people and making friends. My mobile full up with names 
and numbers of friends before it was just family and doctor’s number.  I was really 
depressed before but now really happy. Before I have nothing to do, now every day I wake I 
think ‘yes volunteer work!’ or ‘meeting friends!’” 
“With me I enjoy talking to people once the conversation starts it’s easy.”  
 “Well there is plenty going on, you don’t have to sit indoors like I did all those years. Until a 
year ago you know. There’s people you can go to you’ve only got to speak to your doctor.” 
“Said to doctor going mad sitting indoors. Met woman in doctor’s surgery talked about 
getting out of the house a bit more.”  
“Last summer was the best one I’ve had since my surgery because I’ve got somewhere to 
go….. It’s better to sit with company sometimes than sit by yourself.’‘ 
“With the people I’m with now I think I’ve got what I wanted.” 
 
Renewed hope for the future 
“Done qualifications at Tesco. The Job Centre really happy with me. Before I was on 
capacity benefit and I thought I’ll change my life and I have I’m really happy. I do want to 
work and Job Centre knows that.” 
“We spoke about me volunteering and that was the best part for me because I felt like I had 
purpose.” 
“Teamed me up with an old boy with Alzheimer’s and we go and do a bit of gardening in our 
local park in winter we do cooking it gets me out. Before that I was just sitting indoors doing 
my medical procedures.” 
“The depression had taken so much from me and that (volunteering) was giving me 
something back. It allowed me to keep my hand in so when I was ready and able to go back 
to work to work I wouldn’t have been not working been since 2012.” 
 “I’ve got references and skills that are current. And being able to help somebody else.  It got 
me out of the house.” 
“That gave me the motivation to think ‘I think I might be ready to go back to work. It helped 
me deal with my depression, prepared me to go back to work and made me feel useful.”  
“It gave me hope, it gave me a sense of purpose, it gave me an avenue for dealing with what 
was going on for me without feeling like I was being a burden to someone.” 
 
Feeling empowered 
“We went through a list of places…I said to her St Luke’s but I didn’t think I could get in 
there. But she managed to make a meeting with the girl who does the gardening.” 
 
“I’ve been invited to attend groups discussing social prescribing… for me that gave me 
information but I felt really good as well because I felt like I was at work!” 
“I could go in say a bit about how I was feeling and there was things I could do as well.” 
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The experience of the social prescribing pathway 
 “You feel able to offload if you need to, discuss your fears - it’s about not being so hard on 
myself and validating myself.” 
“I’d say do it because it’s changed my life for the better.”  
“She (social prescribing co-ordinator) understands – she speaks my language. She 
understood me and I understood her. She’s a lovely lady.” 
 “It’s done me a world of good; taken me out of the house, given me a routine and given me 
a sense of purpose and…hope. It’s given me back my confidence.” 
“We (social prescribing co-ordinator) had good talks, I was suicidal at the time, I was 
emotional and run down I don’t know anyone but she was very helpful to talk to.” 
 
“It’s (social prescribing) is about the time that you’re given, the freedom that you’re given and 
the practical tools that you’re given at the end.” 
 “I would say it’s worth going for it (social prescribing) if they were in the same situation I was 
in like, there’s nothing worse than being by yourself.  Even on days when I feel a bit off peak 
I can go round there no-one’s going to force me to do anything leave me sitting there if I just 
want to sit down have a chat there’s someone there to chat to there’s always someone there 
to chat to, there’s always someone in there, it’s nice just to go in and watch a bit life go past 
sometimes. Before that I weren’t going nowhere I was lucky if I’d go to the shop to get some 
milk.” 




Main Themes: Social Prescribing Co-ordinators 
 
Working with clients 
 
“It’s Collaborative work. Not about me telling you how to live your life or what to do. Just two 
heads are better than one.” 
 
“I think it’s having a very honest dialogue. Some people have an expectation that we’re 
going to fund them to do a course. I always make it very clear it’s about the goals they want 
to set for themselves. This is often the first time they’ve had to generate ideas for 
themselves, used to being told what to do by the GP. Tell me what to do! Well what do you 
want to do? That’s quite a big thing, I think, for some people.” 
 
“Instead of focusing on what someone can’t do, look at what has gone well and the skills 
they have. A large no of people I work with go towards the volunteering route because it is 
about giving something that helps your self-esteem and your sense of purpose.” 
 
Empowering clients 
“I’ve had a client who I recommended help us with our service. She was taking and now 
she’s giving.” 
 
“ A client with MS, we looked for a society for her, found one in Walthamstow and now she’s 
a founder member of one in Hackney. She’s getting support and she’s supporting other 
people.” 
 
“The model is the strength – it changes people’s lives.” 
 
 
Interviews with community organisations: main themes 
 
Confusion about role in pathway 
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“…I didn’t know if I it was OK to refer an individual on. Did I need to send them back to FA?  
But now I know that it’s OK that’s great. I can actually give them some support round that 
and that’s great.” 
 
“Can we link to other organisations so we can refer on? We’ve had other companies come in 
and deliver interventions we don’t offer and weren’t involved with SP but we got them 
involved.” 
 
Communication and feedback 
“What would help would be if I knew who FA were referring so that I can keep track of them 
and maybe either like monitor their usage and feed that back to them. I have info but not 
feeding back to FA.” 
 
 




Appendix 3: Evidence from FA  
Evidence of intervention impact come from data collected by FA on a range of different 
outcomes (see chart below). This evidence has not been independently evaluated so should 
only be regarded as illustrative of other dimensions of the impact social prescribing may 
Social Prescribing Case Study from the Department of Health publication 
Excellence In Public Health and Wellbeing - A Celebration Event (https://s3-eu-west-
1.amazonaws.com/media.dh.gov.uk/network/482/files/2015/03/20150303-Final-edition-of-brochure.pdf) 
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have on clients. Some 96% of people (N=53) who completed the pre (green line) and post 
(blue line) intervention recovery star (see chart below) showed an improvement in at least 
one of the measures with major improvements in social networks, trust/hope and managing 
mental health.  
 







Appendix 4 : Logistic regression and methodological details 
 
Table 4 – Treatment effect (Analysis of outcome variables between groups) 
 
Regression on outcome 
differences (between 
baseline and follow-up) 
against treatment group 
(Coef.; p value) 
With controlled 
variables (age, sex, 
ethnicity, work status 
and living 
arrangement) 
(Coef.; p value) 
General health score -0.029; 0.838 0.127; 0.472 
Wellbeing (past week) 
(range 0-6) 
-0.089; 0.714 -0.013; 0.966 
HADS Anxiety score (range 
0-21) 
-0.542; 0.409 -0.119; 0.892 
HADS Depression score (0-
21) 
0.679; 0.283 0.857; 0.289 
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HADS score (0-41) 0.232; 0.845 0.906; 0.557 
Social integration score (0-
20) 
0.023; 0.963 -0.073; 0.905 
 
Logistic regressions was conducted to identify the relations between treatment effect (group) 
and control variables. P values were recorded to highlight the significance of the relations. It 
was found that except age and gender, all other control variables are significantly correlated 
with treatment. Analysis was completed to investigate if the treatment had any effect on the 
health outcomes. Derived variables recording the difference between baseline and follow-up 
scores were generated for each set of outcome variables. A simple linear regression model 
was used first on each outcome difference against treatment. The model was then adjusted 
by control variables, including age, gender, ethnicity, living arrangement and work status. All 
outcome variables (general health score, wellbeing at past week, HADS anxiety score, 
HADS depression score, HADS score, social interaction score, number of regular activities, 
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  NHS Number:   
  
  Home Telephone Number 
 
    
  Mobile Number               
Language Advocate Needed 
Yes    /   No   
Language:   
 
 
Date of Referral:   
  
Reason(s) for referral (please tick):  
o Socially isolated   
o Frequent attenders to GP/A+E   
o Presenting with a social problem   
o Mild-moderate mental health problems  
o Keen to participate in non-clinical activities but not aware of what’s happening locally  
o Other (please specify) ………….. 
 
 
Relevant Medical Conditions 
 
Other Relevant Information, e.g. carries and EpiPen/other care agencies involved 
 
 
I have obtained consent for sharing the above medical information Yes    /    No   
 
Please tick to indicate that you have entered Reed Code 8TO9 “Referral to social prescribing service” 
on Emis    
 
I confirm that this patient does not meet any of the exclusion criteria (see Key Information sheet 
attached)  
 
PLEASE FAX THIS REFERRAL TO 020 3119 0077 
The Client Will Then Be Contact Directly to Arrange an Appointment 
City & Hackney Social Prescribing 
Well Being Coordinator 
Ability Plaza 
Unit 6, Arbutus Street 
London 
E8 4DT 
Tel: 020 7249 8109 
Fax: 020 3119 0077 




Key Information for Referrers 
 
Individuals will be offered an appointment with a Social Prescribing Coordinator who will conduct an 
in-depth needs assessment and then facilitate activate participation in local community based services, 
e.g. lunch clubs, gardening groups, benefits advice, exercise groups. 
 
GPs are encouraged to consider referring the following groups of patients: 
 
o Socially isolated   
o Frequent attenders to GP/A+E   
o Presenting with a social problem   
o Mild-moderate mental health problems  
o Keen to participate in non-clinical activities but not aware of what’s happening locally  
 
The three consortia involved in the initial phase of the project: 
 
Rainbow & Sunshine (who are also recruiting diabetic patients) 
South West (who are focussing on isolated over 50s) 
Well (who are focussing on isolated over 50s) 
 
Please do not refer if the patient is: 
 
o A threat to themselves or others  
o In a crisis situation 
o Already got a care plan in action from another organisation 
o Any uncontrolled mental health issues or addictions 
o Unsuitable for group related activities 
o Housebound 
 
Further details of organisations operating locally in the community and voluntary sector can be found 




Social Prescribing is an innovative project, which aims to reduce health inequalities by improving the 
social capital (‘the links that bind and connect people within and between communities’33) in City and 
Hackney. The project is being evaluated by QMW Dept of General Practice and Primary Care. 
 
If you have any comments, questions or suggestions please do not hesitate to contact Sandra Cater as 
we are aiming to actively improve the service in light of any feedback. 
 
‘Some patients say they are simply not very good at speaking. I say: ‘this isn’t traditional counselling 
– simply looking at where you are now, what things are out there that would sit well with your 
interests to compliment your life.’ 34(GP, Social Prescribing 
                                               
33 Marmot Review: Healthy Lives. Health Society 
34 Friedli et al Sept 2012, Dundee 
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PROJECT AIMS 
 reduce social isolation 
 enable individuals to feel more in control, manage their Long Term Condition 
better and improve self- confidence  
 improve health and well-being 
 improve awareness in primary care of community activities available to 
patients  
 increase numbers accessing community activities 
 support individuals to visit the GP or hospital less  
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Appendix 6: Social Prescribing Benchmark table 
This results from literature review and learning events with stakeholders in City and Hackney  
Key elements Ideal Social Prescribing Happening at the moment (April 2015) 









 New and improved relationships between 
primary care and community organisations are 
being created and sustained in the long term 
 Operational level: strong & effective 
partnership between GPs, Social Prescribing   
(SP) coordinators  and community/statutory 
organisations. Shared short-term objectives 
(increased referrals) and long-term objectives 
(improved patients outcomes) 
 Strategic level: collaboration between Clinical 
Commissioning Groups and local /county 
authorities via health and well-being boards or 
other policy networks. Long rather than short-
term strategies. 
 Networks with funding/commissioning 
organisations are built with potential 
engagement and involvement of private sector 
investment (e.g. corporate social responsibility) 
 Ownership of social prescribing is shared 
across the health pathway (from GPs to 
community/statutory organisations and 
patients) 
 Volunteers and volunteer/community 
organisations are active stakeholders in the 
partnership 
 Local expertise of third sector organisations 
valued and considered on an equal footing with 
medical and clinical expertise 
 SP coordinators have 
developed good working 
relationships with GPs and 
are embedded in surgeries 
 SP co-ordinators are 
working well with 
community/statutory 
organisations and continue 
to develop new 
relationships within the 
community. 
 Patient/clients are feeling 
heard and supported 
throughout the Social 
Prescribing pathway 
 
 At the strategic level short-
term, SP is still seen as a 
short-term strategy in its pilot 
stage. Recurrent funding are 
sought to fund it 
 Community/statutory 
organisations feel less sense 
of ownership across the SP 
pathway than GPs and SP co-
ordinators 
 Volunteers are currently 
under-utilised 
 Patients’ steering group 
needs to be set up for future 
projects. 
 Number of referrals from 
primary care to coordinators 
 Operational level: regular 
meetings involving all 
stakeholders to make sure of 
compliance with action plan 
 Formal agreements between 
CCGs and LAs supporting the 
development of SP 
 Joined up resources invested 
from both CCGs and LAs 
 Health and Well-being board is 
aware and committed to SP 
 Regular steering group 
involving patients and 
evidence of how decisions 
have been included in 
evaluation of SP 
 Interviews with stakeholders 
for the qualitative evaluation of 
the study 
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 Patients are accurately represented 
Communication  High awareness of the information about SP 
for everyone, which is easy to access and 
share, (patient leaflets, information boards, 
videos, hard copy of services available in the 
borough) 
 Mixed formats (video, internet, 
leaflets/brochures) 
 Clarity on how to access 
 Branding: patients may not know that they 
have been referred as part of social prescribing 
 Database of community organisations is 
regularly updated 
 Information sharing between stakeholders (e.g. 
health of patients referred) is key (Warmald & 
Ingle, 2004) 
 Clear roles and responsibilities 
 Patients are aware of Social Prescribing when 
being referred 
 Consistent definition of the interventions and 
roles involved in the Social Prescribing 
pathway with relation to other projects 
 I-care database with 
community services is 
available  
 Steering group meetings 
invite a number of 
stakeholders 
 SP Coordinators and 
community organisations 
are aware of their roles 
and responsibilities. 
 Promotion of SP brand 
improved with posters in 
surgeries. 
 New EMIS flagging alert to 
encourage GP referrals 
 ‘I- care’ database is not yet 
updated 
 Lack of standardised feedback 
loop keeping track of client 
progression. GPs in particular 
receiving no information 
regarding patients’ outcomes 
 Uneven participation of GP 
practices. Most referrals came 
from 6-7 practices. Need to 
communicate and persuade 
others to refer more. 
 SP branding unclear to 
patient/clients who are 
requesting a leaflet to take 
home from initial GP 
consultation. More resources 
need to be spent promoting 
the intervention 
 Need for SP coordinators to 
promote further to GPs 
(e.g.GP practice clinical 
meetings, consortia meetings)  
 Survey of patients’ knowledge 
of social prescribing. However, 
danger of patients confusing 
social prescribing with other 
NHS schemes, consultations 
and appointments.  
 Interviews/ focus groups with 
key stakeholders to collect 
information about roles and 
responsibilities  
 
Sustainability  Resources are found to ensure long-term 
sustainability of social prescribing 
 Joined responsibility of local authority and 
CCG 
 Money follows the patient: delivery 
organisations are paid in reason of the number 
and quality of sessions provided and 
depending on the outputs/outcomes achieved 
(Newham CCG) 
 Volunteers are actively engaged in the delivery 
of SP to ensure sustainability 
 Sustainability key in other SP projects (Lee et 
al, 2009) 
 
 Small charge of free 
services available from 
community organisations  
 Service delivery depends 
upon existing resources 
secured by organisations 
via other means than the 
CCG. 
 Some but limited 
involvement of volunteers 
 Plans for a tear-off 
prescription for patient and 
possible funding to follow 
patient? 
 Plan for City and Hackney is 
to make the case for 
sustainability once evidence 
from evaluation is clearer 
 Commitment of resources for 
delivery is limited  
 Greater involvement of 
volunteers could have cost 
saving implications 
 Community organisations 
which have had positive 
impact on SP clients already 
disappearing due to lack of 
continued funding 
 Number of trained volunteers 
engaged in delivery of SP 
 Long term commitment of 
funding and other resources 
allocated to community 
organisations via CCG and 
other commissioning bodies. 
 Amount of funding from Public 
Health (Local authority) 
 Economic evaluation of 
interventions 
 




 Patients steering group to advice on 
development of social prescribing  
 Person-centred approach: patients have an 
active voice and co-produce their health plan 
with SP coordinators 
 Patient/clients actively involved in development 
of the project.  
 Patients choose the type of 
classes/activities they are 
referred to compatibly with 
what is available in their 
local area 
 Patients engaged and 
report positively on their 
experience of the scheme 
 No patient steering group 
exists 
  Positive experience of 
interaction with Well-being Co-
ordinator is key to 
patient/client progression 
through SP pathway 
 Regular steering group 
involving patients and 
evidence of how decisions 
have been included in 




 There is a clear structure of ethos, principles 
and responsibilities shared by all the 
stakeholders 
 The information about the SP and community 
services are shared on the other websites 
such as CCG, GP sites, FA site. 
 Standardized measures employed to 
evaluate the health and behaviour changes 
demonstrating the outcomes in a long term 
 Service User’s Card implemented enabling 
easier data collection. Electronic cards could 
be given to each participant to enable 
tracking their use of community organisations 
(smart card). 
 
 I-care database exists 
 SP coordinators identify 
and keep regular contact 
with most organisations 
active on the ground 
 Some cost-effectiveness 
data collected 
 Data collected by some 
community organisations 
regarding participants who 
attended the activities 
 SP coordinators are 
collecting some data about 
participants’ progression 
 ‘I- care’ database still not 
updated 
 Limited data on cost 
effectiveness  
 No standardised process of 
data collection or feedback 
regarding patient progression  
 
 Economic evaluation  
 Monitoring through a ‘smart 
card’ given to each patient 
would improve quality of data 
capture and reduce evaluation 
costs 
 See other rows 
 Need to select carefully period 
for follow up and tool to be 
used to measure the impact of 










 GP practices are aware of SP (Gidlow et al, 
2005) 
 The vast majority of GPs approve of SP and 
refer patients accordingly 
 Primary care professionals recognise a more 
balanced relationship between bio-medical 
model and social prescribing  
 Patients are referred by health practitioners, 
nurses, physiotherapists, psychologists and 
other qualified health care staff 
 GP awareness of SP 
increased; new flagging 
system on EMIS 
introduced 
 
 Low referral numbers still a 
problem  
 Referrals patchy across GP 
surgeries 
 Well-being co-ordinators 
report a number of 
inappropriate referrals 
 Survey of GP and other 
healthcare professionals to 
measure awareness of Social 
prescribing (via education 
events) 
 Measurement of GP referrals, 
OOH and use of emergency 
services at various points in 
time 
 GP are regularly informed of 
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 Number of GP referrals, OOH and use of 
emergency services declines over time 
 Expanded GP capacity with increased  
 
the development of Social 
Prescribing in order to 
increase awareness and buy-




 Awareness of services available in the 
community 
 Ability to match patients with services available  
 Ability to understand the needs of patients 
(patient centred process) 
 Volunteers are active part in the delivery of SP 
with potential to ensure sustainability of 
services 
 Minimise the number of drop outs 
 Patients are empowered and have a ‘voice’ in 
the services they are referred to 
 Well-being Coordinators recruited on the basis 
of acknowledged expertise in their role as a 
key component of the intervention. 
 Well-being coordinators 
are enthusiastic, 
professional and effective 
 Work effectively to identify 
needs and facilitating the 
referral process 
 Patient/clients report 
feeling heard by well-being 
coordinators and this stage 
of the pathway seen as 
therapeutic in its own right. 
 Effective signposting to 
available activities 
 Volunteers need to be more 
engaged in service delivery 
(e.g. helping patients). 
Consider expanding 
volunteers’ roles and 
responsibilities 
 Relationship between well-
being-coordinator and 
patient/client key to both 
patient’s progression and 
overall patient’s experience 
 Number of referrals to 
community services over the 
number of referrals from GP 
practices 
 Interviews with patients to 
collect views about well-being 
coordinators and patients’ 
choice 
 Focus groups with well-being 
coordinators to collect info 
about their views about 
process. 








 Services meet the needs and aspirations of 
patients 
 Easy access to services 
 Funding follow patients (funding provided by 
partnership between the CCG and local 
authority). Ambition is to deliver services that 
are free to patients 
 Wide range of services for a wide range of age 
groups 
 Volunteers are engaged and acting as a link 
between patients and community 
organisations; volunteers supporting & 
encouraging patients at the start of SP 
 Services are local to patients and based within 
their communities encouraging social networks 
to develop further. 
 Community organisations 
do not have a plan for 
referrals 
 Community organisations 
do serve a population of 
over 50s. 
 Charge for services is 
often small or free 
 Patients/clients report 




 Need for greater engagement 
of volunteers into helping 
patients 
 Successful community 
projects ending because of 
lack of funding 
 Community organisations 
don’t feel part of SP 
pathway/project 
 Number and engagement of 
volunteers 
 Quality of training for 
volunteers 
 Number of people referred, 
where and how often attended 
 Interviews with case study 
organisations to understand 
their barriers and quality of 
services delivered 
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Appendix 7: Social Prescribing Pathway 
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Appendix 8: Quality of life (EQ5D) questions 
Please tick which statements best describe your own health state today 
1. Mobility Please tick () one  [aQLmobl] 
I have no problems in walking about 
 
I have some problems in walking about  
I am confined to bed  
 
2. Self-care Please tick () one  [aQLself] 
I have no problems with self-care 
 
I have some problems washing or dressing myself  
I am unable to wash or dress myself 
 
 
3. Usual activities such as work, study, housework family or leisure [aQLusac] 
Please tick () one 
I have no problems with performing my usual activities  
I have some problems with performing my usual activities 
 
I am unable to perform my usual activities  
 
4. Pain/Discomfort Please tick () one         [aQLpain] 
I have no pain or discomfort 
 
I have moderate pain or discomfort  
I have extreme pain or discomfort  
 
5. Anxiety/Depression Please tick () one [aQLanxi] 
I am not anxious or depressed  
I am moderately anxious or depressed  
I am extremely anxious or depressed 
   
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